J-Plasma  Clinical References ®

Laparoscopic Treatment of Benign and Malignant Pelvic Disorders Utilizing Helium Plasma: A Retrospective Analysis

ITEM TYPE:

Journal Article

AUTHORS:

Michael R. Manuel

SUMMARY:

Objective:
Assess the clinical and surgical outcomes related to the use of helium plasma, a novel energy device, in the treatment of benign and malignant pelvic conditions.

Methods:
Retrospective chart review of 110 patients who underwent a laparoscopic procedure for the treatment of benign and malignant pelvic conditions treated with helium plasma from May 1, 2015 to February 15, 2017. Data collection included patient demographics, operative details, conversion rate to laparotomy, and incidence of blood transfusion, hospital readmission, and adverse events.

Results:
The mean age was 50.4 ± 12.61 years, and the mean body mass index was 30.6 ± 6.95 kg/m². Medical comorbidity was noted in 52.7% of patients and 33.6% had previous pelvic or gynecologic surgery. The mean surgical time was 94.5 ± 33.68 minutes. There were no conversions to laparotomy. The mean blood loss was 107.0 ± 83.98 mL with one patient receiving a postoperative blood transfusion. There were no surgical site infections and one pelvic abscess occurred. There were no lymphedemas in patients undergoing lymph node dissection and no vaginal cuff dehiscence. The readmission rate was 0.9%. No complications were noted.

Conclusions:
Helium plasma was used successfully to treat patients with benign and malignant pelvic conditions, with no reported complications or conversions to laparotomy.

Top